APA

Vergne-Salle P., Dufauret-Lombard C., Bonnet C., Simon A., Trèves R., Bonnabau H. & Bertin P. (20110915). A randomised, double-blind, placebo-controlled trial of dolasetron, a 5-hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia. : European journal of pain (London, England).

Chicago

Vergne-Salle Pascale, Dufauret-Lombard Carine, Bonnet Christine, Simon Anne, Trèves Richard, Bonnabau Henri and Bertin Philippe. 20110915. A randomised, double-blind, placebo-controlled trial of dolasetron, a 5-hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia. : European journal of pain (London, England).

Harvard

Vergne-Salle P., Dufauret-Lombard C., Bonnet C., Simon A., Trèves R., Bonnabau H. and Bertin P. (20110915). A randomised, double-blind, placebo-controlled trial of dolasetron, a 5-hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia. : European journal of pain (London, England).

MLA

Vergne-Salle Pascale, Dufauret-Lombard Carine, Bonnet Christine, Simon Anne, Trèves Richard, Bonnabau Henri and Bertin Philippe. A randomised, double-blind, placebo-controlled trial of dolasetron, a 5-hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia. : European journal of pain (London, England). 20110915.